Latest Pamidronic acid Stories
This Approval Provides a New Treatment Option for a Patient Population With High Unmet Medical Need THOUSAND OAKS, Calif., Dec.
New research shows when it comes to bone-cancer-related fractures, pain can be reduced by drug treatment, but no one drug is superior.
Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior.
The Food and Drug Administration (FDA) announced today that physicians should reassess patients with osteoporosis who are being treated with a class of drugs called bisphosphonates after three to five years of therapy to determine whether they should continue treatment.
Parker Waichman LLP Files 36 Fosamax Lawsuit on Behalf of Women throughout the U.S.
PLYMOUTH, Minn., June 29 /PRNewswire/ -- Midwest Infusion Center expanded from its previous space at West Health by opening a new infusion center at the City Center Professional Building in Plymouth for patients receiving infusion therapy. Midwest Infusion Center is a unique treatment center designed for patients to receive complex therapies in a safe, comfortable and non-clinical setting.
SCHAUMBURG, Ill., Jan. 19 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL.
By HARWARD, Esther WHEN TWO of Tauranga mum Jenny Noble's three children were diagnosed with a crippling bone disease, they told her they were in so much pain they wanted to die.
By Deena Beasley LOS ANGELES (Reuters) - Amgen Inc. said on Sunday that early results from mid-stage trials of its experimental drug denosumab show that it works at least as well as current therapies to limit bone loss in patients with late-stage cancer.
- A poem in which the author retracts something said in an earlier poem.